Search:

Home |


Uncovering the Truth In Trasylol

By: Peter Kent

How does a drug marketed by a pharmaceutical giant go from superstar to scapegoat in a matter of mere months? That's what doctors who use the injectable drug Trasylol-Aprotinin are asking themselves after recent revelations that the drug, which is used to stop bleeding in 60 percent of heart surgery patients, causes side effects such as kidney failure, heart attack, encephalopathy, stroke and even death.

The drug, which is manufactured by Bayer AG and was approved in the United States in 1993, had been questioned in a January 2006 report by the New England Journal of Medicine, which found that Trasylol upped the risk of kidney failure after heart surgery by 259 percent and linked the drug with renal failure and future heart attacks.

Singing Its Praises

Ironically, the drug had been mentioned in The Washington Post in early January 2006 as an example of a drug so safe that it no longer required clinical study. The article stated that Trasylol dropped the risk of blood transfusions in bypass patients by one-third and that after only 12 of 64 clinical studies, its advantages were clear. The article also included information that suggested if scientists had used the previous results of the drug, which were positive, then additional clinical trials would not have been necessary.

Tides Turn for Trasylol

The above article ran on January 2, 2006. However, once the New England Journal of Medicine study on Trasylol-Aprotinin was published on the risks of approximately 1,000 heart surgery patients, the drug's use began to diminish. Bayer responded by insisting that the study was inherently flawed, but it came to the attention of the Food and Drug Administration (FDA), who warned doctors and patients of the drug's adverse side effects, which include increased risk of heart attack, stroke, and even the deadly brain disease encephalopathy.

Though Bayer has tried to discredit this study and market the drug for other procedures (including hip replacement surgery), lawsuits have begun to flow in as more and more patients have been found who have experienced detrimental side effects from the use of Trasylol-Aprotinin in their heart surgeries.

Have You Suffered Side Effects?

If you or a loved one have suffered side effects, such as stroke, heart attack, encephalopathy or even death, after the use of Trasylol-Aprotinin in a surgical heart procedure, you may be eligible for compensation and damages for your lost wages, medical care, future medical care, loss of consort, and/or emotional and physical pain and suffering. It is advisable to speak with an experienced Trasylol lawyer who can consult on the details of a lawsuit and potential monetary compensation.

Article Source: http://www.newagelivingarticles.com

Use trasylol-aprotinin.legalview.com to garner more information on this ongoing investigation. Also use LegalView's other information portals to learn about controversial drugs similar to Trasylol Aprotinin such as the Avandia risks, found at avandia.legalview.com, or the Vytorin and Zetia side effects.

Please Rate this Article

 

Not yet Rated

Click the XML Icon Above to Receive Articles Via RSS!

 Free Traffic


banner











NewAgeLivingArticles.com » Copyright © 2007 WildWind Enterprises
Terms of Service | Submission Guidelines | Contact Us | Link to Us| Privacy Policy | About Us | Article Submissions With A Click 100's of Sites!

Powered by Article Dashboard